Category: Resources

CATIE Treatment Update 205 – November 2014

Inflammation and its discontents When cells of the immune system encounter invading germs they can become activated and enter into a heightened state of alert. Temporary inflammation during short-lived infections is useful for marshalling the immune response. However, chronic inflammation from an ongoing infection—such as that arising from HIV—can injure organ-systems, causing them to slowly… Read more »

By Allison Carter Public health professional with the Faculty of Health Sciences at Simon Fraser University and the Epidemiology and Population Health Program at the BC Centre for Excellence in HIV/AIDS. BC Community-Based Research Coordinator for CHIWOS. Read original article More than half of all people living with HIV worldwide are women, and yet they… Read more »

HepCBC’s December Bulletin

Before reading this newsletter, HepCBC is asking for you and your friends to help make hepatitis C drugs more accessible and affordable. You can do so by answering a few simple questions to help HepCBC make a great Patient group Input submission to CADTH (Canadian Agency for Drugs and Technologies in Health) about the value… Read more »

The HIV/AIDS and TB Section of the Public Health Agency of Canada’s Centre for Communicable Diseases and Infection Control are pleased to announce the release of HIV and AIDS in Canada: Surveillance Report to December 31, 2013. An electronic copy of the report will be available on the PHAC website shortly. ************************************************************************************************************ Il nous fait… Read more »

CATIE: HepCinfo Update 5.23

New and Noteworthy Harvoni (ledipasvir + sofosbuvir) approved by Health Canada In October, Health Canada approved the hepatitis C medication Harvoni (ledipasvir + sofosbuvir) for people over the age of 18 with genotype 1 hepatitis C virus. In clinical trials, the cure rate for this combination was 94% to 100%. Ledipasvir and sofosbuvir are both… Read more »

PHAC: Release of HIV and HCV G&Cs Performance Reports

The Public Health Agency of Canada is pleased to share the first Federal Initiative to Address HIV/AIDS in Canada: National Grant and Contributions Performance Measurement Report – 2012-13 and the first Hepatitis C Prevention, Support and Research Program: National Grants and Contributions Performance Measurement Report – 2012-13. These reports summarize performance measurement findings for 2012-13,… Read more »

Contents: HOW PUBLIC IS OUR PUBLIC HEALTH CARE? B.C. doctors urge provincial ministers to take a stand on public health care Private Edmonton clinic blurring line between public, private health care: documents The problem with the “Canadian model”   REACTIONS TO EBOLA ECHO STIGMA OF HIV “History repeating itself”: AIDS activists slam Cuomo for “stigmatizing”… Read more »

“Canada is a world leader in targeting and criminalizing people living with HIV. People are being charged with aggravated sexual assault and thrown in prison for not disclosing their status, even when there was virtually no risk of transmission. Our laws are based on stigma and fear.” “We’ve asked local community members to tell you… Read more »

by Derek Kline, Outreach Nurse, Clinical Prevention Services, BCCDC, & Anna Kline, M.Psych., RCC Anxiety and sexually transmitted infections (STIs) go hand-in-hand.[1,2]  Worry can take many forms and is often related to fears about social stigma.[2,3]  Waiting for the right time to get tested or waiting for results can also increase anxiety. Given these things,… Read more »

CATIE: World AIDS Day Resources

CATIE has a wealth of suggested resources available in support of World AIDS Day. These resources are available for download or order on their website. You can also see CATIE’s World AIDS Day web section for more information and resources.

by Titilola Falasinnu, MHS, School of Population and Public Health, University of British Columbia Background Numerous research studies have explored the association between risk behaviors and infection with an STI. From a clinician’s perspective, the decision to recommend testing to a patient for a particular STI is usually informed by testing recommendations from public health… Read more »